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Neurofibromatosis is a collective name for a group of genetic conditions in which benign tumours affect the
nervous system. Type 1 is caused by a genetic mutation in the NF1 gene (OMIM 613113) and symptoms can vary
dramatically between individuals, even within the same family. Some people have very mild skin changes, whereas
others suffer severe medical complications. The condition usually appears in childhood and is diagnosed if two of
the following are present: six or more café-au-lait patches larger than 1.5 cm in diameter, axillary or groin freckling,
2 or more Lisch nodules (small pigmented areas in the iris of the eye), 2 or more neurofibromas, optic pathway
gliomas, bone dysplasia, and a first-degree family relative with Neurofibromatosis type 1. The pattern of inheritance is
autosomal dominant, however, half of all NF1 cases are ‘sporadic’ and there is no family history. Neurofibromatosis type 1
is an extremely variable condition whose morbidity and mortality is largely dictated by the occurrence of the many
complications that may involve any of the body systems. We describe a family affected by NF1 in whom genetic
molecular analysis identified the same mutation in the son and father. Routine MRI showed pontine focal lesions in the
eight-year-old son, though not in the father. We performed a four years follow-up study and at follow-up pontine
hamartoma size remained unchanged in the son, and the father showed still no brain lesions, confirming thus an
intra-familial phenotype variability.
Keywords: Brainstem tumor, Diffusion weighted imaging, Intra-familial phenotype variability, MR-spectroscopy,
Neurofibromatosis, Pontine hamartomaBackground
Neurofibromatosis type 1 (NF1) (OMIM#162200) [1]
has a prevalence of 1 in 4,000 individuals in the general
population. It is an extremely variable condition whose
morbidity and mortality is largely dictated by the occur-
rence of the many complications that may involve any of
the body systems [2]. CNS tumours may lead to major
morbidity and mortality, despite the fact that most are
grade I pilocytic astrocytomas [3]. Optic pathway [4] and
brainstem [5] gliomas are the prevalent CNS tumours in
NF1. Studies in the literature, most of which are based
on children, have shown that these tumours are less ag-
gressive than their counterparts in non-NF1 patients [5].
In particular, as a rule, brainstem gliomas behave much* Correspondence: pasquale.parisi@uniroma1.it
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reproduction in any medium, provided the orless aggressively in NF1 patients than in other patients.
Hamartomas or focal areas of high signal intensity can
be seen in ≤ 93% of patients with NF-1 [6]. They tend to
show T2 hyperintensity but no mass effect, edema, or
contrast enhancement. The brain stem, cerebellar
peduncles, and basal ganglia are the most preferred loca-
tions. The exact nature of hamartomas is not clear. Al-
though the morphologic criteria are often diagnostic in
making a differentiation between hamartomas and brain
stem glioma, some cases can present diagnostic difficul-
ties and MRspectroscopy can provide additional infor-
mation. Zamboni et al. detected using diffusion tensor
imaging, globally elevated fractional anisotropy (FA) and
decreased apparent diffusion coefficient (ADC) values in
the mature brains of patients with NF-1, which is most
likely a consequence of diffuse and basic alterations in cere-
bral microstructure that result from the underlying gene
mutation. Diffusion changes might be a more sensitived. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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aging findings [7].
We describe a family affected by NF1 in whom genetic
molecular analysis identified the same mutation in the son
and father. Routine MRI showed pontine focal lesions in
the eight-year-old son, though not in the father. Interest-
ingly, an isolated focal pontine localization is exceptionally
reported in brainstem lesions NF1 associated in pediatric
age [3-5]. MR spectroscopy (MRS) imaging and diffusion-
weighted imaging (DWI) were also performed in both
father and son. At follow-up, four years later pontine
hamartoma size remained unchanged in the son, and the
father showed still no brain lesions, confirming thus an
intra-familial phenotype variability.Figure 1 Neuroradiological and clinical evaluation performed at adm
and subcortical cerebellar white matter on the basis of FLAIR signal alterati
(B); MRS documented increased Cho/Cr resonance intensities in the voxels
brainstem (inside mean value Cho/Cr: 2.43; at the border Cho/Cr: 1.70 (C, D
hemispheres (right side Cho/Cr: 2.06 (E) (left side Cho/Cr: 0.80 (F). MRSI vox
Nor brain lesions neither metabolic changes in the father’s MRS (H).Case presentation
An 8-year-old boy was referred to our Child Neurology
Outpatient Service because of “headache” attacks with
“migraine without aura” (MoA) features, according to
the International Classification of Headache Disorders.
Although the boy’s father was affected by Neurofibroma-
tosis type I, diagnosed according to the international cri-
teria, he had always refused to undergo the molecular
genetic analysis for confirmation of the clinical diagno-
sis; the boy’s late paternal grandfather was also reported
to have been clinically affected by NF1. The boy’s birth
was uneventful and his neurological and psychomotor de-
velopment were normal, apart from a slight speech delay.
Weight at birth was 3.200 kg, head circumference 35 cm
and length 50 cm. There was no family history of epilepsyission in the child and his father. MRS positioned on the brainstem
on images (A); presence of numerous cafe´ au lait patches in the child
located inside and at the border of the MRI signal alterations in the
), in normal appearing white matter between the cerebellar
els at the level of focal cerebellar lesion documented Cho/Cr: 1.29 (G).
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childhood vertigo. His 14-year-old brother and his mother
were normal at the physical examination. Several EEGs per-
formed between three and eight years of age were reported
to be normal. The paediatric, neurological and ophthalmo-
logic examinations confirmed the clinical diagnosis of NF1,
with the presence of numerous cafe´ au lait patches
(Figure 1B) with axillary freckling and five Lisch nodules
(iris hamartomas) seen at the slit-lamp examination. More-
over, the neurological examination showed cranial nerve
impairment from the 9th to 12th cranial nerves and slight
right upper arm impairment at the Mingazzini item. In
view of the strongly suspected diagnosis of NF1 and the
afore-mentioned neurological impairment, conventional as
well as diffusion tensor and multivoxel spectroscopy MR
investigations in both the father and son were planned. The
MRI examination was performed repeated at the 6-month
and the fourth-years follow-up visit.
The father’s MRI study excluded brain focal lesions and
metabolic changes, whereas the son’s MRI study revealed
cerebral lesions (Figure 1A), with focal abnormalities on
T2-weighted images in the basal ganglia, brainstem, cere-
bral and cerebellar regions.
The ADC and FA values of the cerebral and cerebellar
apparent normal white matter were not significantly differ-
ent compared with those of 10 pediatric normal controls,
(recruited from our outpatient pediatric surgery, with no
reported neurological disease, after parents provided writ-
ten informed consent to the study), so the results are not
here reported.
On the contrary, the MRS revealed differences between
the brainstem voxel lesion and the border as well as differ-
ent cerebellar hemispheres values; increased Cho/Cr reson-
ance intensities in the voxels located inside and at the
border of the MRI signal alterations in the brainstem
(inside mean value Cho/Cr: 2.43; at the border Cho/Cr:
1.70 (Figure 1C, D ), significantly different values in normal
appearing white matter between the cerebellar hemispheres
(right side Cho/Cr: 2.06 (Figure 1E) (left side Cho/Cr: 0.80
(Figure 1F). MRSI voxels obtained at focal cerebellar lesion
documented Cho/Cr 1.29 (Figure 1G). There were no
metabolic changes in the father’s MRSI (Figure 1H).
To confirm the clinical NF1 diagnosis, molecular gen-
etic analysis was performed at the Mendel Institute in
Rome. After informed consent was obtained DNA from
peripheral blood was extracted from each patient (son
and father) by means of one of several standard proce-
dures. The identification of NF1 gene mutations was car-
ried out using dHPLC on a 3500HT WAVE DNA fragment
analysis system (Transgenomic, Crewe, UK) equipped with
a DNASep column (Transgenomic, Crewe, UK). PCR pro-
ducts were examined for heteroduplexes with a separation
flow rate of 1.5 ml/min, through a 5% linear acetonitrile
gradient. The first base (position +1) of the initiatormethionine is taken as the start of the cDNA. dHPLC and
sequencing analyses detected the mutation c.586 + 1G > A
in intron 4b of the NF1 gene. The presence of this mutation
was confirmed in our patient’s father [8,9].
Ten months after having come to our paediatric head-
ache centre, the patient’s clinical picture has substantially
remained the same as well as after four years of follow-up.
MRI showed unchanged the size of pontine hamartoma at
four years of follow-up (Figure 2: 2007 and 2010).
Conclusions
The family we describe confirms that a father and son
with the same NF1 genetic defects may not present the
same clinical picture, confirming thus the possible oc-
currence of an intra-familial variability [1,2].
To date, contrasting literature data have been published
on the usefulness and early predictive value of both DWI
and MRS [7,10-14]. Eastwood et al., investigating the brain
of children with NF1 by means of DWI, reported myelin
disorder, such as reduced amount of myelin and increased
myelin turnover or demyelination [11]. No significant dif-
ferences in metabolites in the normal appearing brain in
NF1 patients (either with or without focal lesions) when
compared with healthy volunteers were reported [12], while
others [13] reported abnormal metabolic changes in the
corresponding area of normal appearing brain at MRI in a
patient who had a hamartoma at an MRI examination per-
formed one year before. Alkan A et al. described in a total
of 30 NF1 patients, higher ADC values both in “T2 hyper-
intensities” and in the normal appearing locations as hippo-
campus and thalamus in the patients with NF1. They
showed that the detection of lesions might be independent
of MRI appearance in NF1, i.e. although the brain is
affected, MRI appearance may be normal. Therefore, they
suggested that DWI and ADC values should also be
utilized in the delineation of brain involvement of NF1
patients [10].
Hsieh HY et al. investigated the neurological complica-
tions and characteristics of intracranial lesions in patients
with NF1 in Taiwan. They found that neurofibromatosis
bright objects are frequent neuroimaging findings in
patients with NF1, and are at high risk of transforming into
tumors. The incidences of epilepsy and young-onset cere-
bral infarction in NF1 patients in this study are higher than
those in the general population. Authors concluded that
neuroimaging studies are essential for NF1 patients to de-
termine the extent of neurological complications, although
the imaging findings may not be completely correlated with
the clinical manifestations [14].
The normal appearing cerebellar white matter in our
child, when compared with the contralateral not affected
hemisphere and with healthy ten controls, did not show
nor ADC neither FA significant changes. On the con-
trary, at MRS we observed an increased Cho/Cr ratio
Figure 2 MRI (Flair, T2, and T1 sequences) performed in the child at the admission (2007) and four years later (2010). 2007: Hamartoma
in the right pontine region and swallen aspect of the omolateral cortico-spinal tract. High signal intensity foci diffuse in the cerebellar emispheres
(T2 hyperintensities). 2010: unmodified size of the pontine hamartoma and persistent bulge of the right cortico-spinal tract. Unchanged the UBOs
lesions too.
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disease, may be related to increased membrane
turnover [13]. In other words, in our NF1 affected child,
a possible correlation between DWI and MRS was not
documented. In fact, in the normal appearing cerebellar
white matter we found normal ADC and FA value while
at MRS a Cho/Cr ratio increase was demonstrated
(Figure 1C-G). Nevertheless, being not specific of NF1
patients we can add nothing about the possible predict-
ive value of Cho/Cr ratio increase in normal appearing
white matter. Anyway, it should be stressed that this is
just a family report and MRS findings here reported
need to be confirmed in a large NF1 paediatric sample.
In addition, we would like to spend few sentences on
the pontine hamartoma found out in our child and the
differential diagnosis of brainstem lesions in paediatric
age. The advent of MR imaging has simplified the diagnosis
of brainstem tumors and it has also given new information
that has allowed the identification of subgroups with differ-
ent therapeutic options and prognoses [4,5]. As above
reported, optic pathway [4] and brainstem [5] gliomas are
the prevalent CNS tumours in NF1. The pons is the most
common location of tumors originating in the brainstem in
paediatric age, whose prognosis for most patients is defin-
itely poor. On the contrary, in NF1 affected children, an
isolated focal pontine tumor localization represents an ex-
ceptional finding [4,5] and brainstem tumors showgenerally a very much better prognosis. In fact, it should be
stressed that the brainstem tumors associated with NF1 are
currently considered a subgroup with further separations
into focal and diffuse tumors. Brainstem tumors are
detected in about 9–10 % of patients with NF1 and medulla
localization represents the most common site (70-82%)
while there is a marked pontine predominance in subjects
without NF1 [4]. Although brainstem tumors of NF1 show
an identical imaging appearance to those that occur outside
the spectrum of NF1, their clinical behavior is often strik-
ingly different and lesion may show a clear slow tumor
growth. Even in patients with tumors that have imaging
appearances identical to diffuse pontine tumors often have
relatively indolent clinical course. Our patient, in fact, after
four-year of follow-up showed both unchanged clinical pic-
tures and unchanged size of pontine hamartoma. Most T2
hyperintensities regress with age and seem to be benign,
however, children with a large number and volume of T2
hyperintensities should be followed closely with regular
neuroimaging examinations because of an increased risk of
proliferative change. T2 hyperintensities occur commonly
in children with NF1 and are most prevalent between the
ages of 4 and 10. Paul D. Griffiths et al. have shown a high
frequency of brain tumors in children with NF1 and
demonstrated proliferative change T2 hyperintensities in
11% of 46 children; they described 8 cases with brain
tumors, 6 of which seemed to have developed after the
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from T2 hyperintensities, and 1 tumor that was not over-
lapped in position with a previous T2 hyperintensities [15].
Recent works have established that T2 hyperintensities do
not have developmental potential, although changes in FA
despite the disappearance or reductions of T2 hyperintensi-
ties have been confirmed due to DTI, supporting thus the
hypothesis that microstructural damage occurs in specific
brain regions of NF1 patients [16,17]. We found a single le-
sion in our patient and even if from literature data seems
that the developmental potential is to be reserved in case of
multiple lesions, we followed closely our patient, with regu-
lar neuroimaging examinations, essential for NF1 patients
to detect any change in the extent of neurological compli-
cations, not completely correlated with the clinical
manifestations.
Finally, we believe that there are at least some good
reasons that make this family so interesting to be
described. Firstly, four years of follow-up allowed us to
confirm both the well known slow growth of these
lesions (Figure 2: 2007 and 2010) and the peculiar focal
pontine localization. Secondly, comparing father and
son, the well known intra-familial phenotype variability,
even at the MRI, MRS and DWI investigations levels,
was confirmed.Consent
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